Panbio

Panbio is a prominent diagnostic company specializing in the development and manufacture of rapid test kits for infectious diseases. Originally established in Australia, the company became a global leader in flavivirus diagnostics, particularly for Dengue fever and West Nile virus. In 2008, Panbio was acquired by Inverness Medical Innovations, which later became Alere and was subsequently acquired by Abbott. Today, the Panbio brand is a core component of Abbott's rapid diagnostics portfolio, notably featuring the Panbio COVID-19 Antigen Self-Test used extensively during the pandemic. The company's products are essential tools for point-of-care testing and public health surveillance in both clinical and field settings.